Klinikum der Universität München Grosshadern

München, Bavaria 81377

0 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma, Lymphoma, Non-Hodgkin

Studies at this site

• Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors — Completed
• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early